By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prima Biomed 

Unit 7, 79 - 83 High Street

Melbourne  Victoria  3101  Australia
Phone: 61-3-9854-5700 Fax: 61-3-9854-5777



Company News
Prima Biomed (PRR.AX) Abstracts Accepted For Poster Presentation At ESMO Symposium On Immuno-Oncology 10/7/2016 9:06:33 AM
Prima Biomed (PRR.AX) Release: European Patent Grants For IMP731 Antibody 8/25/2016 10:24:35 AM
Prima Biomed (PRR.AX): Operational Update 8/19/2016 9:01:16 AM
Prima Biomed (PRR.AX) Receives NASDAQ Notice Of Bid Price Deficiency 8/10/2016 10:27:00 AM
Prima Biomed (PRR.AX) Collaborates In Investigator Sponsored New Clinical Trial For IMP321 In Solid Tumors 7/13/2016 10:59:20 AM
Prima Biomed (PRR.AX) Announces First Safety, Pharmacokinetics And Immuno-Monitoring Data From Phase IIb Clinical Trial Of IMP321 6/22/2016 11:57:59 AM
Prima Biomed (PRR.AX) To Maintain NASDAQ Listing 6/7/2016 9:14:14 AM
Prima Biomed (PRR.AX) Surges on $293 Million License Deal for CVac 5/12/2016 6:04:31 AM
Prima Biomed (PRR.AX) Release: Japanese Patent Grants For IMP321 In Cancer 5/2/2016 11:04:01 AM
Prima Biomed (PRR.AX) Release: IMP321 Safety And Immune Monitoring Data Published In Clinical Cancer Research Journal 3/16/2016 9:46:25 AM